FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Medical Devices

Baze At-home Blood Nutrient Test Cleared

FDA clears a Baze 510(k) for its at-home blood collection process and its use to assess blood nutrient status.

Medical Devices

Medtronic Gets OK for PulseSelect Ablation Trial

FDA gives Medtronic approval to proceed with an IDE trial (PULSED AF) to evaluate the safety and effectiveness of its PulseSelect Pulsed Field Ablatio...

Medical Devices

Cardiologist Sends Affidavit to Hahn

Wisconsin cardiologist Nalini Rajamannan contacts FDA commissioner Stephen Hahn over the agencys decision not to provide information to patients who w...

Federal Register

Animal User Fee Reporting Info Collection

Federal Register notice: FDA seeks comments on an information collection extension for Reporting Associated With Animal Drug and Animal Generic Drug U...

Federal Register

Info Collection on Electronic Product Radiation

Federal Register notice: FDA seeks comments on an information collection extension for Electronic Products 21 CFR Parts 1000 Through 1050.

Federal Register

Cardene Not Withdrawn Over Safety/Efficacy: FDA

Federal Register notice: FDA determines that Chiesi USAs Cardene (nicardipine hydrochloride) injection, 25 mg/10 ml, was not withdrawn from sale for s...

Human Drugs

BsUFA User Fee Assessment Guidance

FDA publishes a guidance on changes in the Biosimilar User Fee program.

Medical Devices

FDA Cites GE Healthcare Cybersecurity Issues

FDA highlights potential cybersecurity vulnerabilities in some GE Healthcare Clinical Information Central Stations and Telemetry Servers.

Federal Register

Class 2 for Computer Triage/Notification Software

Federal Register notice: FDA classifies radiological computer-aided triage and notification software into Class 2 (special controls).

Federal Register

CADx Software for Suspect Cancer Lesions Into Class 2

Federal Register notice: FDA classifies the radiological computer-assisted diagnostic (CADx) software for lesions suspicious for cancer into Class 2 (...